TillaCare Inc. exhibits at APIC 2023 in Orlando June 26-28.
Come and visit us at the booth # 966In honor of APIC 2023, we have a FREE EDUCATIONAL GIFT FOR YOU! If you are a #IP Infection Preventionist, contact TillaCare today for access to a FREE EDUCATIONAL GIFT om how the UriCap Female can be used to reduce catheter days. The deadline to request the free educational gift is Fri. 6/15/23 11:59 PST. Free gifts are offered on a first come, first serve basis and are electronic only. No Cash value. One free educational gift per person.
iMEDicare appointed distributor for TillaCare products in the UK and Ireland
TillaCare Ltd. an Israeli innovator and producer of Urine Collection Devices entered a distribution agreement with iMEDicare a leading distributor in the UK and Ireland with focus on innovative urology products. The company iMEDicare sees a great potential for the UriCap Female product both for urine collection in incontinence but also for sampling of urine from incontinent women.
Today, we passed an important milestone when TillaCare had its US patent allowed for the UriCap Female. The UriCap Female received U.S. Patent No. 11,666,474 and is also patented in Israel, China, and the EU. The market is looking for a safe, soft, leak-free external urine collection device that does not use vacuum or glue. It allows us to change the way we think about urine incontinence in women. TillaCare gives these women, all over the world, a new opportunity to safely collect urine and diagnose Urinary Tract Infections.